Autori: Yablonovitch A
| Naslov | Clinical potential of circulating tumor DNA (ctDNA)-based molecular response (MR) and baseline blood-based tumor mutational burden (bTMB) for monitoring response to firstline (1L) chemoimmunotherapy in advanced squamous non-small cell lung cancer (sqNSCLC) (Meeting Abstract) |
| Autori | Ciardiello F Feng Z Smith NR Andric Zoran G Shell S Yablonovitch A Guezel G Scheuenpflug J |
| Info | ANNALS OF ONCOLOGY, (2022), vol. 33 br. 7, Suppl. 7, str. S1050-S1051 |
| Projekat | Merck |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
